(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LEQSELVI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LEQSELVI

ST13

US500000098567738

Class

5

Filing

98567738

Registration

8162853

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

04/17/2026

Trademark type

Combined

Nice classes

5

Filing date

05/24/2024

Registration date

03/03/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/03/2026

Last transaction

04/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/30/2025

First use in commerce

06/30/2025

Drawing code

3

Owner type

03

Owner location

Princeton, NJ, US

Examiner

TAYLOR, DAVID T

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "LEQSELVI" in red, with stylized navy and yellow curved lines above the word.

Holders and representatives

Holders

Sun Pharmaceutical Industries, Inc.

Representatives

Craig Kuchii Sun Pharmaceutical Industries, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparationsmedicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/03/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/03/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/06/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/06/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/17/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/17/2026

ALIE

ASSIGNED TO LIE

01/17/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/14/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/14/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/14/2026

GNRT

NON-FINAL ACTION E-MAILED

01/14/2026

CNRT

SU - NON-FINAL ACTION - WRITTEN

01/14/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/14/2026

EX1G

SOU EXTENSION 1 GRANTED

01/14/2026

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/14/2026

IUAF

USE AMENDMENT FILED

08/22/2025

EEXT

SOU TEAS EXTENSION RECEIVED

08/22/2025

EISU

TEAS STATEMENT OF USE RECEIVED

08/22/2025

EXT1

SOU EXTENSION 1 FILED

08/21/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/25/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2024

PUBO

PUBLISHED FOR OPPOSITION

12/31/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/09/2024

DOCK

ASSIGNED TO EXAMINER

12/09/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/02/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/02/2024

NWAP

NEW APPLICATION ENTERED

05/24/2024

Continuous trademark protection

Get notified about every new filing that threatens LEQSELVI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.